A phase I study to evaluate the safety and pharmacokinetics of S-CKD602 [belotecan] in patients with advanced malignancies
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Belotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 28 Nov 2005 New trial record.